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Inner mitochondrial membrane peptidase 2-like (IMMP2L) protein is a mitochondrial inner membrane
peptidase that cleaves the signal peptide sequences of cytochrome c1 (CYC1) and mitochondrial glycerol
phosphate dehydrogenase (GPD2). Immp2l mutant mice show infertility and early signs of aging. It is
unclear whether mitochondrial respiratory deﬁciency underlies this phenotype. Here we show that the
intermediate forms of GPD2 and CYC1 have normal expression levels and enzymatic function in Immp2l
mutants. Mitochondrial respiration is not diminished in isolated mitochondria and cells from mutant
mice. Our data suggest that respiratory deﬁciency is not the cause of the observed Immp2l mutant
phenotypes.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Cytochrome c1 (CYC1) and mitochondrial glycerol phosphate
dehydrogenase (GPD2) are mitochondrial inner membrane pro-
teins that need bipartite signal sequences to guide them to their
ﬁnal destination: the mitochondrial-targeting signal sequence and
the mitochondrial inner membrane-targeting signal sequence. The
mitochondrial targeting signal sequence guides the precursor
proteins to the mitochondrial matrix, and is then cleaved by
mitochondrial processing peptidase in the matrix. The mitochon-
drial inner membrane-targeting signal sequence guides the inter-
mediate proteins to the inner membrane, and is ﬁnally cleaved by
mitochondrial inner membrane peptidase. Yeast mitochondrial
inner membrane peptidase has one noncatalytic subunit Som1p
[1], and two catalytic subunits Imp1p and Imp2p, each with non-
overlapping substrates. Imp1p cleaves the mitochondrial inner
membrane-targeting signal sequences from cytochrome c oxidase
subunit 2 (Cox2p), cytochrome b2 (Cyb2p), NADH-cytochrome b5B.V. This is an open access article u
brane peptidase 2-like; CS,
llular acidiﬁcation rate;
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consumption rate; VDAC1,
uinol-cytochrome-c reduc-
omplex II, succinate-ubiqui-reductase (Mcr1p) and mitochondrial glycerol-3-phosphate dehy-
drogenase (Gut2p) [2–5], whereas Imp2p cleaves the signal
sequence from cytochrome c1 [6].
Mammalian IMMP1L and IMMP2L are homologs of yeast Imp1p
and Imp2p [7,8]. Mouse IMMP2L has two substrates, CYC1 and
GPD2 [9]. However, in yeast, Gut2p (a homolog of GPD2) is a
substrate for Imp1p [5]. Substrates for mammalian IMMP1L have
not been described, although mammalian DIABLO/SMAC was
suggested as an IMMP1L substrate [8]. Yeast Imp1p substrate
Cyb2p lacks a mammalian ortholog. Yeast Imp1p substrates Cox2p
and Mcr1p have mammalian orthologs, but appear to lack a typical
cleavable signal peptide sequence [10].
Immp2lmutant mice show a series of abnormalities in different
organs, which can be classiﬁed as either age- dependent or
-independent. Age-independent phenotypes include infertility
and reduced food intake, which are proposed to be caused by
superoxide negation of nitric oxide [9,11]. Age-dependent pheno-
types include spermatogenic damage in male mice [12], bladder
dysfunction [13], and ataxia in old mutant mice but not in age-
matched normal control mice [14]. These phenotypes are pro-
posed to be caused by chronic oxidative stress resulting from
increased mitochondrial superoxide generation. While the oxida-
tive stress hypothesis is consistent with the observed phenotypes,
it remains unclear whether the phenotypes are caused by func-
tional deﬁciency of IMMP2L substrates.
CYC1 is one of the 11 subunits of complex III (ubiquinol-
cytochrome-c reductase) [15], which is located on thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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transfer. Ubiquinol from complex I (NADH:ubiquinone oxidore-
ductase) and complex II are oxidized by mitochondrial complex III
to reduce cytochrome c, where CYC1 is the subunit transferring
the electron to cytochrome c [16]. In yeast, the intermediate form
of Imp2p substrate Cyt1p (i-Cyt1p, with the inner membrane
targeting signal sequence uncleaved) has normal localization in
the mitochondria and is respiratory competent [6]. However, the
N-terminal signal peptide sequences of yeast Cyt1p and its mouse
homolog CYC1 show little homology, and the entire mature
sequences are only 58% identical. In addition, yeast and mouse
complex III have different numbers of subunits [17]. Furthermore,
patients with CYC1 missense point mutations showed reduced
complex III activity and insulin-responsive hyperglycemia [18].
Thus, it remains unclear whether the enzymatic function of the
intermediate form of CYC1 (i-CYC1) is affected in Immp2l mutant
mice.
GPD2, another IMMP2L substrate, catalyzes the conversion of
glycerol-3-phosphate to dihydroxyacetone phosphate, reducing
the enzyme-bound FAD. Together with the cytosolic glycerol
phosphate dehydrogenase (GPD1), they form the glycerol phos-
phate shuttle, which uses the interconversion of glycerol-3-phos-
phate and dihydroxyacetone phosphate to transfer reducing
equivalents into mitochondria, resulting in the reoxidation of
NADH formed during glycolysis. It also remains unclear whether
the enzymatic activity of GPD2 is impaired in Immp2lmutant mice
due to the presence of uncleaved signal sequences.
The present study was designed to address questions regarding
the enzymatic activities of IMMP2L substrates in Immp2l mutant
mice. We ﬁnd that CYC1 and GPD2 are functional in Immp2l
mutant mice and conclude that mitochondrial respiration deﬁ-
ciency is not the cause of the observed phenotypes.Materials and methods
Animals
The development and characterization of the Immp2l mutant
mice has been described previously [9]. Mice were housed in the
pathogen-free animal facility of Wake Forest University Health
Sciences. Experiments were conducted in accordance with the
National Research Council publication Guide for Care and Use of
Laboratory Animals, and approved by the Institutional Animal Care
and Use Committee of Wake Forest University Health Sciences.
Mice were kept in microisolator cages with 12-h light/dark cycles
and were fed ad libitum. Genotypes of the mice were determined
by coat color. Normal homozygous mice (þ/þ) were albino due to
the FVB background. Heterozygotes (þ/) were slightly pigmen-
ted due to the expression of tyrosinase from one copy of the
transgene. Homozygous mutant mice (/) were darkly pigmen-
ted due to the expression of tyrosinase from both copies of the
transgene. Mice were fed a chow diet (Prolab, RMH3000).
Quantitative RT-PCR analysis of gene expression
Total RNA was extracted from hypothalamic tissues with Turbo
DNase (Ambion) to eliminate DNA contamination, and reverse
transcribed as described previously [19]. Primer sequences for
mouse Dock4, Lrrn3, Dnajb9, Immp2l exons 3–6 and Immp2l exons
3–7 have been described previously [9]. Pbip gene was used as the
internal control, and primer sequences were tcgtctttggactctttggaa
(forward primer) and agcgctcaccatagatgctc (reverse primer). RNA
from 4 control and 4 mutant mice were compared. Each sample
was assayed three times.Preparation of mitochondrial and cytosolic proteins from mouse
tissues
Testicular and brown fat tissues were excised from 2 to
3-month-old mice. Mitochondrial and cytosolic proteins were
prepared as described previously [20]. Protease inhibitors
(0.5 mM PMSF and 1 Complete Protease Inhibitor Cocktail from
Roche) were included to prevent protein degradation.
SDS-PAGE and Western blot analyses
Tissue extracts were prepared from 2 to 3-month-old mice in
RIPA buffer including protease inhibitors. Mitochondrial, cytosolic
proteins, and tissue extracts were separated by SDS-PAGE, trans-
ferred to a nitrocellulose membrane, and incubated with anti β-
actin (Sigma, 1:5000), anti-GAPDH (Abcam, 1:500), anti-CYC1
(ProteinTech Group, 1:1000), anti-GPD2 (Abnova, 1:500), anti-
VDAC1 (Abcam, 1:2000). Horseradish peroxidase (HRP)-conju-
gated secondary antibodies were purchased from Pierce. Chemi-
luminescent reagents from Pierce were used to visualize the
protein signals under the LAS-3000 system from Fujiﬁlm. The
Integrated Density function from ImageJ software was used to
quantify the expression of individual proteins after normalization
by β-actin or GAPDH (for cytosolic proteins or total tissue extracts)
and VDAC1 (for mitochondrial proteins).
Oxygen consumption rate (OCR) of isolated mitochondria
Whole hind limb skeletal muscle from a control and an
Immp2l / mouse (2–3 months) was used for mitochondria
isolation, following the protocols described previously [21–23].
Mitochondrial protein concentrations were determined using the
BCA protein assay kit (Thermo Scientiﬁc, Rockford, IL). Mitochon-
drial OCR was measured using a Seahorse XF24 Extracellular Flux
Analyzer (Seahorse Biosciences, Billerica, MA). 10 mM succinate
was used as the substrate with the addition of 2 mM rotenone; 5 mg
mitochondrial protein was loaded in each well. Three to four
replicates of each sample were analyzed for the mean and SD.
Following an initial 7 min of equilibration, ADP (2 mM), oligomy-
cin (2 mM), FCCP [carbonyl cyanide 4-(triﬂuoromethoxy) phenyl-
hydrazone, 6 mM] and antimycin (2 mM) were added successively
to achieve the ﬁnal concentration as given in parentheses.
Mitochondrial citrate synthase (CS) activity
CS activity of isolated muscle mitochondria was assayed with
the kit from Sigma (Cat no. CS0720), according to the manufac-
turer's instructions. Assays were performed at 25 °C in a 96-well
plate with 4 mg mitochondrial protein per well. Formation of
5-thio-2-nitrobenzoic acid was monitored with a SpectraMax M5
Microplate Reader (Molecular Devices, Sunnyvale, CA) at 412 nm.
Before and after the addition of oxaloacetate, absorbance was
monitored for 3 min. The difference of the slopes was calculated to
obtain the CS speciﬁc activity. CS activity was calculated based on
the TNB extinction coefﬁcient of 13.6 mM1 cm1 at 412 nm. The
pathlength of 0.553 cm was adopted for the 200 ml reaction in the
96-well plate.
2.7. Mitochondrial complex III activity
Mitochondrial complex III activity was assayed as described
previously [24]. To prepare decylubiquinol, 10 mg decylubiquinone
(Sigma, D7911) dissolved in 400 ml of nitrogen-saturated hexane
was mixed with 400 ml of 1.15 M sodium dithionite, and vortexed
until colorless. The organic phase was collected, and the decylu-
biquinol was recovered by evaporating the hexane under nitrogen.
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10 mM HCl) and stored in aliquots at 80 °C. Oxidized cyto-
chrome c was from Sigma (C3131). 300 ml reaction mixture
(15 mg mitochondrial protein and 60 mM cytochrome c) was added
to a cuvette. After the addition of 3 ml decylubiquinol (stock
concentration 15 mM, ﬁnal concentration about 150 mM), reduc-
tion of cytochrome c was monitored at 550 nm once every second
for 1 min with a SpectraMax M5 Microplate Reader (the chamber
temperature was set at 30 °C). The assay was repeated with the
addition of 1 mg Antimycin A (Sigma, A8674). Antimycin A-sensi-
tive activity was calculated for the complex III activity. The
extinction coefﬁcient of cytochrome c is 21 mM1 cm1.Mitochondrial GPD2 activity
Isolated mitochondria from mouse skeletal muscle were frozen
and thawed. GPD2 activity was determined by methods described
by Dawson et al. [25] with the addition of complexes I, II, and III
inhibitors as described by Orr et al. [26]. The assay was run in a 96-
well plate, and each well contained 40 mg total mitochondrial
protein in a total volume of 200 ml. The reaction mixture contained
50 mM KH2PO4–NaOH buffer (pH 7.6), 25 mM-L-3-glyceropho-
sphate, 50 mM DCPIP (2,6-dichlorophenolindophenol, Sigma),
4 mM rotenone, 2.5 mM antimycin A, and 1 mM malonate. The
assay was started by the addition of mitochondrial proteins, and
the decrease in absorption at 600 nm was recorded by a Spec-
traMax M5 Microplate Reader (Molecular Devices, Sunnyvale, CA)
pre-warmed to 37 °C. The progress curve was linear during the
ﬁrst 3–5 min; data from the ﬁrst 3 min were used to determine the
reaction velocity. The reduction of absorption at 600 nm in the
absence of mitochondrial protein was negligible. Extinction coefﬁ-
cient of DCPIP at 600 nm was taken to be 21 mM1 cm1.Fig. 1. Expression of Immp2l but not other nearby genes is affected in Immp2l
mutant mice. (A) Genes in the affected region. E1–E7 are the seven exons of Immp2l
gene. The red triangle in intron 6 indicates the location of the foreign DNA insertion
and the 50-kb deletion. Short arrows indicate the location of the primers used for
qRT-PCR. Long arrows indicate the distances between the deletion and the adjacent
genes. The diagram was not drawn to scale. (B) qRT-PCR comparison of expression
of genes in the same region as Immp2l. Four control and three mutant mice were
analyzed. Means7SEM are presented. No signiﬁcant differences were found by
ANOVA. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)Skeletal muscle myoblasts isolation, myotube differentiation, and
oxygen consumption analysis
Myoblasts were isolated from two pairs of young control and
mutant mice (aged 6 months), and three pairs of age-matched old
control and mutant mice (aged 22, 25 and 29 months), following
the procedures described previously [27] but with modiﬁcations.
The proliferation medium contained Dulbecco's Modiﬁed Eagle
Medium (DMEM) supplemented with 20% fetal bovine serum, 10%
horse serum, 1% chicken embryo extract, and 5 ng/ml bFGF, and
the differentiation medium contained 10% horse serum without
bFGF. Four to ﬁve days after isolation, the myoblasts were collected
and ﬁltered through a cell strainer to remove debris. The cells
were further re-suspended in proliferation medium, seeded in V7
cell culture plates (Seahorse Biosciences, Billerica, MA) (coated
with 1:60 diluted Matrigel) at a concentration of 104 cells/well.
After 3–4 days of proliferation, the medium was changed to
differentiation medium for another one to two days. The cells
were then analyzed with a Seahorse XF24 Extracellular Flux
Analyzer as described previously [28]. Five to 11 replicates of each
sample were analyzed for the mean and SD. Cells were incubated
in Seahorse XF assay media with 5.56 mM D-Glucose, 1 mM
sodium pyruvate, and 2 mM glutamax-1 added then pH titrated
to 7.4 using NaOH. Following an initial 36 min of equilibration,
oligomycin (0.75 mM), FCCP (1.0 mM), and antimycin (1.0 mM) plus
rotenone (1 mM) were added successively to achieve the ﬁnal
concentrations (shown in parentheses). OCR (oxygen consumption
rate) and extracellular acidiﬁcation rate (ECAR) were normalized
to total protein obtained using a BCA kit after Seahorse analysis.Statistical analysis
Two-tailed Student's t-tests were performed to compare means
of two groups. Tukey's post-tests following analysis of variance
(ANOVA) were performed for means of more than two groups.
Paired t-tests were also performed to compare mitochondrial
GPD2 activities. For measurements with more than one variant,
two-way ANOVA was performed followed by Bonferroni post-
tests. P o0.05 was accepted as statistically signiﬁcant.Results
Immp2l gene but not adjacent genes are affected in Immp2l / mice
In Immp2lmutant mice, a transgenic insertion in intron 6 causes
a 50 kb deletion in this 250 kb-intron [9] (Fig. 1A). The result is the
disruption of normal expression of Immp2l mRNA after exon 6.
Immp2l transcripts 5′ to exon 7 can be detected, but full-length
Immp2l mRNA is undetectable. Three genes, Dock4, Lrrn3, and
Dnajb9, are near this affected region, and Lrrn3 is within intron
4 of Immp2l. Although mRNA of all the three genes was detected
by non-quantitative RT-PCR [9], it is unclear whether their
expression level could be affected. Here we used quantitative RT-
PCR to further examine whether the expression levels of the
adjacent genes are affected, which could not be answered by
non-quantitative RT-PCR. Since Lrrn3 is mainly expressed in the
brain [29], brain expression of the three genes in Immp2l mutant
mice was compared by quantitative RT-PCR (qRT-PCR). No sig-
niﬁcant differences were observed in the expression levels of the
genes between control and mutant mice (Fig. 1). Consistent with
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transcripts in RT-PCR analysis, Immp2l primers spanning exons
3 and 6 (Immp2lF and Immp2lM) detected similar expression
between control and mutant mice in qRT-PCR (Fig. 1B). Immp2l
primers spanning exons 3 and 7 (Immp2lF and Immp2lR) could
only detect speciﬁc ampliﬁcation from normal control mice
(threshold cycle Ct¼29 cycles), but not from mutant mice
(Ct437 cycles).
IMMP2L substrate proteins have normal expression and
compartmentalization in Immp2l / mice
Immp2l is expressed in all tissues, and its mutation affected
CYC1 processing in all tissues examined in our previous study [9].
Mitochondrial and cytoplasmic proteins were prepared from
mutant mice to determine whether the inability to cleave the
signal sequence of CYC1 and GPD2 (the two known IMMP2L
substrates) could affect the compartmentalization and expression
of these two proteins. GPD2 has relatively high expression in
brown adipose tissue [30]. We prepared mitochondrial and cyto-
solic proteins from brown adipose tissue of control and mutant
mice; GPD2 was found in the mitochondrial but not the cytosolic
fractions (Fig. 2A). CYC1 is widely expressed in all tissues. We
examined CYC1 in the testis, an organ affected in Immp2l / mice
[9,12]. Like GPD2, it was also detected in the mitochondrial but not
the cytosolic fractions (Fig. 2A), demonstrating that the proteins
are properly translocated to the mitochondria. This is consistent
with observations in yeast, where the intermediate form of Cyt1p
(i-Cyt1p) is correctly localized in the mitochondria of IMP2 (the
Immp2l homolog) mutant yeast [6]. Compared with voltage-
dependent anion channel 1 (VDAC1), a mitochondrial outer
membrane protein, IMMP2L substrates showed similar expressionFig. 2. Expression of IMMP2L substrates in Immp2lmutant mice. (A) CYC1 and GPD2 expr
and β-actin were used as mitochondrial and cytosolic markers, respectively. (B) C
(C) Densitometry comparison of VDAC1 expression in muscle and liver of control and m
skeletal muscle; Li: Liver. (D) Western blot analyses of VDAC1 expression between controbetween control and mutant mice, in the tissues examined (testis
and muscle for CYC1, brown adipose tissue for GPD2, Fig. 2A and
B). These data showed that loss of IMMP2L activity does not affect
the expression or the compartmentalization of CYC1 and GPD2.
A previous study reported no differences in qPCR analyses of
mitochondrial DNA content between testicular cells of control and
mutant mice [12], suggesting that the Immp2l mutation does not
affect total mitochondrial mass of testicular cells. Western blot was
performed to compare mitochondrial content in more tissues from
control and mutant mice. We analyzed VDAC1 expression relative
to glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a cytosol
protein, in muscle and liver tissue lysates from 5-month-old mice.
The VDAC1/GAPDH density ratios in mutant mice were similar to
those of control mice, indicating no mitochondrial mass deﬁciency
in young mutants (Fig. 2C and D). Ratios also were similar between
control and mutant mice at the age of 24 months.
Mitochondria of mutant mice have normal complex III activity
CYC1 is one of the three redox centers of mitochondrial
complex III. Skeletal muscle is a common source of mitochondria
for mitochondrial complex activity analysis. We wondered
whether the intermediate form of CYC1 (i-CYC1) could compro-
mise the ubiquinol:cytochrome c oxidoreductase activity of mito-
chondria from mutant mice. The size of CYC1 in muscle mitochon-
dria from mutant mice (Fig. 2B) conﬁrmed that it is an inter-
mediate form (i-CYC1). We found no differences in CS and complex
III activities of muscle mitochondria from control and mutant mice
(Fig. 3A). The ratios of complex III/CS were also similar (Fig. 3B).
Cells from CYC1mutant patients show reduced complex III activity
[18]. Normal complex III activity of mitochondria from mutant
mice suggests that i-CYC1 protein is enzymatically active.ession determined byWestern blot analyses in 3–5-month-old mutant mice. VDAC1
YC1 expression in muscle mitochondria from 3 to 5-month-old mutant mice.
utant mice. Data were derived from panel “D”. Means7SEM are presented. Mu:
l and mutant mice using whole tissue lysates. GAPDH was used as a loading control.
Fig. 3. Normal complex III and CS activities of mutant mice. (A) Complex III and CS activities of control and mutant mice. Means7SEM of six mice (3–5 months) are
presented. Complex III activity was expressed as the amount cytochrome c reduced in mmol/min/mg. CS activity was expressed as the amount of 5-thio-2-nitrobenzoic acid
(TNB) formed in mmol/min/mg. Differences were not statistically signiﬁcant between control and mutant mice by ANOVA. (B) Similar complex III/CS activity ratios between
controls and mutants. No statistically signiﬁcant differences were found by t-test (p¼0.49). (C) GPD2 activity of mitochondria from control and mutant mice. Measurements
were done with the same mitochondrial preparations used for complex III activity assay. Values linked by lines were from mitochondria preparations from littermates
sacriﬁced on the same dates.
Fig. 4. Normal mitochondrial respiration of Immp2l mutant mice. Mean7SEM of
5 pairs are presented. No signiﬁcant difference was found by ANOVA.
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No difference was observed in GPD2 activity in frozen/thawed
muscle mitochondria between control and mutant mice
(7.8171.79 nmol/min/mg, N¼6 from control mice;
9.25 71.76 nmol/min/mg, N ¼6 for mutant mice; p¼0.58 by t-
test). Mitochondrial samples were isolated on different days from
one control and one mutant mouse (littermates) for experiments
requiring fresh mitochondria. We noticed that GPD2 activity
shows relatively large intra-group variations. This could be caused
by the fact that mice of the same genotype were sacriﬁced at
different dates for tissue collection. Supporting our reasoning,
tissues from control and mutant mice sacriﬁced at the same days
had similar values. When compared by paired t-test, mitochondria
from mutant mice showed even higher GPD2 activity (p ¼0.0109,
paired t-test). The data exclude GPD2 enzymatic deﬁciency in
mutant mice.
Mitochondrial respiration of mutant mice is not diminished
Isolated mitochondria from skeletal muscle of 3–5-month-old
control and mutant mice were analyzed for their oxidative
phosphorylation. Mitochondria from control and mutant mice
had similar oxygen consumption rates (OCRs) at all states: when
only substrate is present (state 2); when respiration is stimulated
by addition of ADP to stimulate ATP synthesis or uncoupling
reagent FCCP, allowing the inward ﬂow of protons across the inner
membrane without ATP synthesis, and when respiration is in-
hibited by ATP synthase inhibitor oligomycin or complex III
inhibitor antimycin A (Fig. 4). No defects of oxidative phosphor-
ylation were noted in mitochondria isolated from mutant mice.
Respiration and glycolysis of myoblast-derived skeletal muscle
myotubes from mutant mice are normal
Myoblasts were isolated from skeletal muscles of control and
mutant mice and differentiated into myotubes. The OCR (reﬂecting
mitochondrial respiration) and extracellular acidiﬁcation rate
(ECAR, reﬂecting glycolysis) were compared between myotubes
differentiated from myoblasts of control and mutant mice. Differ-
entiated myotubes from 6-month-old mutant mice had similar
OCR and ECAR traces as myotubes from their age-matched con-
trols (Fig. 5A and B). Cell numbers were conﬁrmed as similar bydetermining protein concentrations after the Seahorse reading.
The data suggest that cells from control and mutant mice have
similar rates of mitochondrial respiration and glycolysis. Similar
observations were made in differentiated myotubes from 22–29-
month-old control and mutant mice (Fig. 5C and D).Discussion
CYC1 and GPD2 are two known substrates for IMMP2L, a
peptidase on the mitochondrial inner membrane that cleaves the
space-sorting signal sequences from the precursors of its sub-
strates. The signal peptide sequences of CYC1 and GPD2, also
mitochondrial inner membrane proteins, remain unprocessed in
Immp2l mutant mice [9]. Immp2l mutant mice show normal
embryonic and postnatal development, but exhibit abnormalities
in multiple systems, including infertility and a 30% reduced food
intake [9,11]. In addition, some abnormalities, including bladder
dysfunction [13], ataxia [14], and spermatogenic impairment [12],
develop as mice age. Based on our observation of increased
mitochondrial superoxide generation in the mutant mice, we
Fig. 5. Respiration and glycolysis of in vitro differentiated myotubes. (A and B) Representative OCR (A) and ECAR (B) traces of myotubes from two pairs of 6-month-old
control and mutant littermates. Data shown are means7SD of 5 replicates. (C and D) OCR (C) and ECAR (D) traces of myotubes from old mice. Traces were representative of
three pairs of control and mutant littermates (aged 22, 25, and 29 months respectively). Presented were means7SD of 6 replicates from mice of 22 months. Oligo:
oligomycin; anti: antimycin; FCCP: carbonyl cyanide 4-(triﬂuoromethoxy) phenylhydrazone; Rot: rotenone; and BG: no cell background.
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phenotypes. However, whether CYC1 and GPD2 activity deﬁciency
also contributes to the observed mutant phenotype is not clear.
We conﬁrmed that Immp2l expression is affected due to
disruption of exon 7, the portion of Immp2l mRNA 3′ to the
transgene insertion site. The adjacent genes, Dock4, Lrrn3, and
Dnajb9, are not affected in the mutants. Dock4 and Dnajb9 knock-
out mice are unavailable; Lrrn3 knockout mice have increased
body fat and enhanced glucose tolerance (http://www.informatics.
jax.org/marker/MGI:106036). These phenotypes are different from
those of Immp2l mutant mice, suggesting that the Lrrn3 gene does
not contribute to the phenotype of Immp2l mutant mice.
CYC1 and GPD2 were both observed in the mitochondria but
not the cytosol in mutant mice. In addition, CYC1 and GPD2
expression were not affected in the mutants. Thus, IMMP2L
deﬁciency does not affect the expression of its substrates. Further-
more, mitochondria from mutant mice had normal complex III
activity (CYC1 is a subunit of complex III) and higher than normal
GPD2 activity. The intermediate forms of CYC1 and GPD2 are
enzymatically functional, consistent with the observation that
yeast i-cyt1p (a CYC1 homolog) is respiratory competent [6].
Furthermore, myoﬁbers from mutant mice showed both normal
oxygen consumption (an indication of mitochondrial respiration)
and normal extracellular acidiﬁcation rates (an indication of
glycolysis). Considering our previous ﬁndings that mutant mice
have normal complex I and complex II activities and cellular ATP
levels [9], we conclude that the phenotype of Immp2lmutant mice
is unlikely to be caused by mitochondrial respiratory deﬁciency.
Most analyses were done with tissues from young mice. We think
that this is appropriate since the primary cause must also be
observed when young. We agree that examining old tissues may
provide more information about the combined effects of the
primary defects and age. However, using 2-year-old mice for theseexperiments is impractical considering the cost and time needed
to generate the mice.
We used myoﬁbers and skeletal muscle-derived mitochondria
for respirometry analyses because these are common sources of
materials for such analyses. Similar analyses using other tissues,
especially those most affected in the mutants (e.g. the testis and
the brain), could reinforce our argument. CYC1 frommuscle lysates
of mutant mice has larger than normal size, demonstrating that
IMMP2L activity is lost in muscle tissues. We cannot examine the
size of GPD2 in muscle lysates because of its relatively low
expression in skeletal muscle. However, it is unlikely that GPD2
processing in muscle does not depend on IMMP2L activity. Since
the intermediate forms of CYC1 and GPD2 are functional in
skeletal muscle, it is logical that they are functional in other
tissues.
This work suggests that respiratory deﬁciency is unlikely the
cause of phenotypes observed in Immp2l mutant mice. Our
previous works linked the abnormalities found in mutant mice
to oxidative stress, either through superoxide negation of nitric
oxide [9,11], or through detrimental effects of increased levels of
reactive oxygen species [12–14]. Supporting our argument, we
observed increased superoxide generation in mitochondria from
mutant mice when using endogenous substrates [9]. In addition,
multiple oxidative indices (carbonyl, 4-Hydroxynonenal) demon-
strated oxidative stress in tissues from mutant mice [12,14].
Finally, testes from mutant mice have signiﬁcantly increased
catalase expression [12], consistent with increased superoxide
generation and thus hydrogen peroxide levels.
Interestingly, complex III (of which CYC1 is a subunit) and
GPD2 can generate superoxide as a byproduct [26,31–35]. Muta-
tions in three of the 11 complex III subunits have been described in
patients, but the pathological mechanism is unclear (MITOMAP: A
Human Mitochondrial Genome Database. http://www.mitomap.
org, 2013). GPD2 haploinsufﬁciency was described in a patient
M.S. Bharadwaj et al. / Redox Biology 2 (2014) 1008–10151014with nonsyndromic mental retardation, but whether GPD2 was
the cause is unclear [36]. However, conditional knockout of a gene
coding for the Rieske iron–sulfur protein (a complex III subunit) in
mice causes oxidative stress in the brain [37], conﬁrming that
perturbance of complex III can cause oxidative stress. We propose
that retention of the signal sequences on CYC1 and/or GPD2 does
not affect their ability for electron transfer, but increases the
leakage of electrons to oxygen during electron transfer. It remains
unknown how electron leakage is increased and whether CYC1 or
GPD2 is the greater contributor to increased superoxide genera-
tion. We also cannot exclude the contribution of possible uni-
dentiﬁed IMMP2L substrates.
In conclusion, the present work demonstrates that Immp2l
mutant mice have no mitochondrial respiratory deﬁcit, suggesting
that respiratory deﬁciency is unlikely to be the cause of the
observed Immp2l mutant phenotypes.Acknowledgments
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